A report of 28 cases of 3-year follow-up after liver transplantation for advanced hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 10, Issue 14, 2004, Pages 2134-2135

  Wang, De Chen ^a   Zhang, Tong Lin ^a   Song, Shi Bing ^a   Yuan, Jiong ^a   Xiu, Dian Rong ^a   Yang, Xiao Xia ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; FOLINATE CALCIUM; IODINATED POPPYSEED OIL;

ADVANCED CANCER; ARTICLE; BILIARY TRACT DISEASE; CANCER MORTALITY; CANCER RECURRENCE; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; METASTASIS; PERIOPERATIVE PERIOD; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; VARICOSIS; ADULT; LIVER TUMOR; MALE; MORTALITY; SURVIVAL;

ADULT; CARCINOMA, HEPATOCELLULAR; CAUSE OF DEATH; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; SURVIVAL ANALYSIS;

EID: 4043121630     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i14.2134     Document Type: Article

References (5)

1. Frilling A, Malago M, Broelsch CE. Current status of liver transplantation for treatment of hepatocellular carcinoma. Dig Dis 2001; 19: 333-337
2. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403
3. Herrero JI, Sangro B, Quiroga J, Pardo F, Herraiz M, Cienfuegos JA, Prieto J. Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver transplantation 2001; 7: 631-636
4. Varela M, Sala M, Llovet JM, Bruix J. Treatment of hepatocellular carcinoma: is there an optimal strategy? Cancer Treat Rev 2003; 29: 99-104
5. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RTP, Fan ST, Wong J. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-1171